BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-364@pharmaconomics
DTSTAMP:20260707T044950Z
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260630
SUMMARY:ARQT PDUFA — ZORYVE
DESCRIPTION:The FDA's approval decision on ZORYVE for plaque psoriasis is due Jun 29\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1787306/000178730626000039/pressreleaseex991q12026.htm\n\nTrack it: https://www.pharmaconomics.com/e/364
URL:https://www.pharmaconomics.com/e/364
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ARQT catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR